A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) vs. doxorubicin alone in metastatic/recurrent breast cancer (MBC): a National Cancer Institute of Canada (NCIC-CTG) study
A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) vs. doxorubicin alone in metastatic/recurrent breast cancer (MBC): a National Cancer Institute of Canada (NCIC-CTG) study. Proc Annu Meet Am Soc Clin Oncol. 1996; 15:A59.